HSPA4 Expression is Correlated with Melanoma Cell Proliferation, Prognosis, and Immune Regulation

Xudong Wang1,2,3, Zhiyong Li1, Jianhong Xu1

  • 1Outpatient Department of Yangfangdian, Southern Medical District of Chinese PLA General Hospital, Beijing, 100843, People's Republic of China.

Abstract

Insights

Heat shock protein A4 (HSPA4) is elevated in cutaneous malignant melanoma (CMM) and promotes tumor growth. High HSPA4 expression indicates poor prognosis and may influence the tumor microenvironment, suggesting its potential as a diagnostic marker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Heat shock protein A4 (HSPA4) is implicated in various human diseases.
  • The role of HSPA4 in cutaneous malignant melanoma (CMM) has not been fully elucidated.

Purpose of the Study:

  • To investigate the expression, diagnostic, and prognostic value of HSPA4 in CMM.
  • To explore the correlation of HSPA4 with gene alterations, methylation, and immune cell infiltration in CMM.

Main Methods:

  • Analysis of HSPA4 gene and protein expression in CMM using public databases.
  • Cell proliferation assays (CCK8) to assess HSPA4's effect on melanoma cells.
  • Diagnostic and prognostic value analysis, including ROC curve and survival analysis.
  • Evaluation of gene variations, methylation, immune cell infiltration, and protein-protein interaction networks.

Main Results:

  • HSPA4 mRNA and protein levels are significantly upregulated in CMM.
  • HSPA4 knockdown inhibits melanoma cell proliferation.
  • HSPA4 demonstrates diagnostic value and is associated with poor prognosis in CMM.
  • HSPA4 expression correlates negatively with most immune cells and may be involved in immune suppression and escape.

Conclusions:

  • HSPA4 is upregulated in CMM and impacts tumor growth.
  • HSPA4 serves as a potential diagnostic and prognostic biomarker for CMM.
  • HSPA4 may play a role in regulating the CMM tumor microenvironment and immune response.